Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675376 · ClinicalTrials.gov registry record
Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 419
- Enrollment target
NCT00675376: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT00675376 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 419 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675376 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 419 participants
- Enrollment target
Study Summary
Most people undergoing lung transplantation have chronic obstructive pulmonary disease (COPD), a disease in which the lung airways are partly damaged and obstructed, making it difficult to breathe. This study will enroll people with COPD who are undergoing a lung transplant to examine how their quality of life changes after the transplant procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-09 |
Why NCT00675376 stopped before completion
NCT00675376 is an observational study that tracks outcomes without assigning an intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00675376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00675376 about?
NCT00675376 is a clinical study titled "Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation". Most people undergoing lung transplantation have chronic obstructive pulmonary disease (COPD), a disease in which the lung airways are partly damaged and obstructed, making it difficult to breathe. This study will enroll people with COPD who are undergoing a lung transplant to examine how their qual...
What is the current status of trial NCT00675376?
This trial is currently terminated. The enrollment target is 419 participants. The study started on 2006-01. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT00675376?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia